Cystic Fibrosis and Frailtyh What's in Common?
NCT06020547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139
Last updated 2023-08-31
Summary
The goal of this observational study is to assess the main clinical and anamnestic characteristics, and frailty syndrome in an adult Cystic Fibrosis population. The main question it aims to answer is the possible association of the frailty status with the main clinical, therapeutical characteristics, including the genotyping classification of Cystic Fibrosis patients.
Conditions
- Frailty Syndrome
- Cystic Fibrosis
Sponsors & Collaborators
-
Federico II University
lead OTHER
Principal Investigators
-
Graziamaria Corbi, MD, PhD · Federico II University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-01
- Primary Completion
- 2023-06-01
- Completion
- 2023-08-01
Countries
- Italy
Study Locations
More Related Trials
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000
NCT01651455 ·Status: COMPLETED
-
Assessment of Cognitive Function and Exercise Capacity in Cystic Fibrosis
NCT06175182 ·Status: COMPLETED
-
Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis
NCT04644471 ·Status: COMPLETED ·Phase: NA
-
Neuromuscular Characterisation in Late Adolescent and Adult Cystinosis Patients
NCT05545774 ·Status: COMPLETED
-
Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.
NCT03524859 ·Status: COMPLETED
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF
NCT06468527 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay
NCT00687466 ·Status: UNKNOWN ·Phase: PHASE3
-
MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia
NCT03279965 ·Status: UNKNOWN
-
Markers of Osteoporosis in Cystic Fibrosis
NCT03921060 ·Status: RECRUITING ·Phase: PHASE4
-
Miglustat in Cystic Fibrosis
NCT00742092 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects
NCT03093714 ·Status: COMPLETED ·Phase: PHASE1
-
Correction of Nonsense Mutations in Cystic Fibrosis
NCT03670472 ·Status: RECRUITING
-
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
NCT07251725 ·Status: RECRUITING
-
Evaluation of the Lung Clearance Index
NCT02342951 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis
NCT04451213 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Salt Status in Patients With Cystic Fibrosis
NCT04556162 ·Status: COMPLETED
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Cystic Fibrosis and Cognitive Function
NCT03820349 ·Status: COMPLETED
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
NCT01860872 ·Status: COMPLETED